Palantir After the Reset: Why I Started Buying a Stock That Is Still Expensive
Initiated a 1% position in the growth IRA on June 29 - stock is ~35% off its $207.52 52-week high, but valuation still demands a staged entry rather than an all-in buy. Core product is a governed data layer for regulated institutions - Q1 net dollar retention 150% (up 1,100 bps), indicating high cu…
Published: 2026-06-30 by GNG Research
Tickers: PLTR, NVDA, ZETA, SRFM
I bought Palantir (PLTR) on June 29th. One percent, in the growth IRA model portfolio, at a price that would have looked reckless to me a year ago and looks merely uncomfortable now. The stock is down roughly 35% from its 52-week high of $207.52, and it is still expensive. A 35% haircut sounds like a sale. It is not, at least not yet, and the multiple that is left is exactly why I am staging in instead of buying all at once. That gap between a great company and a fair price is what I want to walk you through. Whether this is a good business is almost insulting to ask after the quarter Palantir just had. The real question is whether you can underwrite a price like this with arithmetic instead of faith. I think you can, barely, if you size it like the high-variance position it is. So let's get right to it.
This is a members-only GNG Research article. Read the full analysis with a GNG Research plan.